Literature DB >> 10779392

Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast.

G Elizondo1, P Fernandez-Salguero, M S Sheikh, G Y Kim, A J Fornace, K S Lee, F J Gonzalez.   

Abstract

The aryl hydrocarbon receptor (AHR) is known to mediate the toxic and carcinogenic effects of polycyclic aromatic hydrocarbons and dioxins. High-affinity AHR ligands, such as 2,3,7, 8-tetrachlorodibenzeno-p-dioxin, have been shown to modify cell proliferation and differentiation. However, the mechanisms by which AHR affects cell proliferation and differentiation are not fully understood. To investigate the role of AHR in cell proliferation, mouse embryonic fibroblasts (MEFs) derived from AHR-null mice were obtained and characterized. Compared with wild-type MEFs, AHR-null cells exhibited a lower proliferation rate with an accumulation of 4N DNA content and increased apoptosis. The expression levels of Cdc2 and Plk, two kinases important for G(2)/M phase of cell cycle, were down-regulated in AHR-null MEFs. In contrast, transforming growth factor-beta (TGF-beta), a proliferation inhibitor in several cell lines, was present at high levels in conditioned medium from AHR-null MEFs. Concomitant with G(2)/M cell accumulation, treatment of wild-type MEFs with TGF-beta3 also resulted in down-regulation of both Cdc2 and Plk. Thus, overproduction of TGF-beta in AHR-deficient cells appears to be the primary factor that causes low proliferation rates and increased apoptosis. Taken together, these results suggest that AHR influences TGF-beta production, leading to an alteration in cell cycle control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779392

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  47 in total

1.  Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells.

Authors:  Barbara C Spink; James A Bennett; Nicole Lostritto; Jacquelyn R Cole; David C Spink
Journal:  Mol Carcinog       Date:  2012-03-02       Impact factor: 4.784

2.  The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells.

Authors:  Daniel P Dever; Lisa A Opanashuk
Journal:  Mol Pharmacol       Date:  2012-02-06       Impact factor: 4.436

3.  Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination.

Authors:  O D Reyes-Hernández; A Mejía-García; E M Sánchez-Ocampo; M A Cabañas-Cortés; P Ramírez; L Chávez-González; F J Gonzalez; G Elizondo
Journal:  Biochem Pharmacol       Date:  2010-05-15       Impact factor: 5.858

Review 4.  Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor.

Authors:  Mark E Hahn; Lenka L Allan; David H Sherr
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

5.  Dioxin receptor expression inhibits basal and transforming growth factor β-induced epithelial-to-mesenchymal transition.

Authors:  Eva M Rico-Leo; Alberto Alvarez-Barrientos; Pedro M Fernandez-Salguero
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

Review 6.  Role of AhR in positive regulation of cell proliferation and survival.

Authors:  Jiuheng Yin; Baifa Sheng; Yuan Qiu; Kunqiu Yang; Weidong Xiao; Hua Yang
Journal:  Cell Prolif       Date:  2016-08-14       Impact factor: 6.831

Review 7.  The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways.

Authors:  Alvaro Puga; Ci Ma; Jennifer L Marlowe
Journal:  Biochem Pharmacol       Date:  2008-09-05       Impact factor: 5.858

8.  Repression of Ah receptor and induction of transforming growth factor-beta genes in DEN-induced mouse liver tumors.

Authors:  Li Peng; Christopher N Mayhew; Michael Schnekenburger; Erik S Knudsen; Alvaro Puga
Journal:  Toxicology       Date:  2008-01-16       Impact factor: 4.221

9.  The unexpected role for the aryl hydrocarbon receptor on susceptibility to experimental toxoplasmosis.

Authors:  Yuriko Sanchez; Juan de Dios Rosado; Libia Vega; Guillermo Elizondo; Elizabeth Estrada-Muñiz; Rafael Saavedra; Imelda Juárez; Miriam Rodríguez-Sosa
Journal:  J Biomed Biotechnol       Date:  2010-01-11

Review 10.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.